Lead Product(s) : Ataciguat
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Rancho Santa Fe Bio
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : This agreement provides RSF Bio with Sanofi’s rights to Ataciguat. With this license, RSF Bio will have the rights it needs to continue development of Ataciguat through clinical trials in the United States and potentially in select international countr...
Brand Name : HMR1766
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 17, 2021
Lead Product(s) : Ataciguat
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Rancho Santa Fe Bio
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?